Vanda Schizophrenia Drug Patentable, Fed. Circ. Says
The Federal Circuit on Friday upheld a patent covering Vanda Pharmaceuticals Inc.'s schizophrenia drug Fanapt, finding it met the U.S. Supreme Court's Mayo standard by outlining a specific method of using...To view the full article, register now.
Already a subscriber? Click here to view full article